Capricor Therapeutics(CAPR) - 2024 Q4 - Earnings Call Transcript

Capricor Therapeutics (CAPR) Q4 2024 Earnings Call March 20, 2025 01:33 AM ET Company Participants AJ Bergmann - CFOLinda Marbán - Co-Founder, CEO & DirectorCatherine Novack - Director - Healthcare Equity Research Conference Call Participants Edward Tenthoff - Sr. Research AnalystLeland Gershell - MD & Senior Biotechnology AnalystJoseph Pantginis - MD & Senior Healthcare AnalystKristen Kluska - AnalystAydin Huseynov - Equity Research AnalystMadison El-Saadi - Research Analyst Operator Good afternoon, ladies ...